Disease: Gliomatosis cerebri
- 'It's not meant to be for life, but it carries on': a qualitative investigation into the psychosocial needs of young retinoblastoma survivors
- <em>UBA2</em> as a Prognostic Biomarker and Potential Therapeutic Target in Glioma
- A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations
- A multi-omics analysis-based model to predict the prognosis of low-grade gliomas
- A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy
- A potassium-chloride co-transporter with altered genome architecture functions as a suppressor in glioma
- A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma
- A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physicians
- A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases
- Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis
- Anti-epileptic drug use during adjuvant chemo-radiotherapy is associated with poorer survival in patients with glioblastoma: A nationwide population-based cohort study
- Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas
- Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes
- Antitumoral Activity of the Universal Methyl Donor <em>S</em>-Adenosylmethionine in Glioblastoma Cells
- Association of Clinical, Tumor, and Treatment Characteristics With Seizure Control in Patients With <em>IDH1/2</em>-Mutant Lower-Grade Glioma
- Automatic brain-tumor diagnosis using cascaded deep convolutional neural networks with symmetric U-Net and asymmetric residual-blocks
- Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker
- Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas
- Classification of Glioblastoma Associated with Immune Checkpoints and Tumor Microenvironment based on Immunogenomic Profiling
- Clinical characteristics and prognostic factors of adult brainstem gliomas: A retrospective analysis of histologically-proven 40 cases
- Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood
- Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma
- Contemporary Management of Pediatric Brainstem Tumors
- Convolutional Neural Networks for Glioma Segmentation and Prognosis: A Systematic Review
- D-Loop Mutations as Prognostic Markers in Glioblastoma-A Pilot Study
- Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors
- DFMO inhibition of neuroblastoma tumorigenesis
- Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients
- Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma
- Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas
- Does the role of non-coding RNA FAM131B-AS2 in glioblastoma go beyond the ATR pathway? A correspondence
- Effect of circFOXM1/miR-218-5p on the proliferation, apoptosis and migration of glioma cells
- Eflornithine (Iwilfin) for high-risk neuroblastoma
- Exchangeable leaders of collectively migrating glioma abuse N-cadherin trafficking
- Executive Functions in a Patient with Low-Grade Glioma of the Central Nervous System: A Case Report
- Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients
- Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
- Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics
- First parechovirus reported case in Saudi Arabia in hospitalized immunocompromised adult patient
- Gedunin modulates cellular growth and apoptosis in glioblastoma cell lines
- Generation of Orthotopic and Subcutaneous Patient-Derived Xenograft Models from Diverse Clinical Tissue Samples of Pediatric Extracranial Solid Tumors
- Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
- Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition
- HIF-1α-mediated LAMC1 overexpression is an unfavorable predictor of prognosis for glioma patients: evidence from pan-cancer analysis and validation experiments
- ID1<sup>high</sup>/activin A<sup>high</sup> glioblastoma cells contribute to resistance to anti-angiogenesis therapy through malformed vasculature
- Identification and characterisation of novel CAR-T cells to target IL13Rα2 positive human glioma in vitro and in vivo
- Identifying tumor type and cell type-specific gene expression alterations in pediatric central nervous system tumors
- Inhibition of signaling protein ERN1 increases the sensitivity of serine synthesis gene expressions to glucose and glutamine deprivations in U87MG glioblastoma cells
- Intraspinal composite gangliocytoma/neuroma and neuroendocrine tumor with vascular malformation: report of a case
- KIAA0040 enhances glioma growth by controlling the JAK2/STAT3 signalling pathway
- Laser Interstitial Thermotherapy (LITT) in Recurrent Glioblastoma: What Window of Opportunity for This Treatment?
- Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation
- LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas
- Long-term Intravital Investigation of an Orthotopic Glioma Mouse Model <em>via</em> Optical Coherence Tomography Angiography
- LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes
- Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy
- Metabolic models predict fotemustine and the combination of eflornithine/rifamycin and adapalene/cannabidiol for the treatment of gliomas
- Methylthioadenosine phosphorylase and p16 as surrogate diagnostic markers for CDKN2A homozygous deletion in brain tumors
- Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of <em>GNAL</em> in glioma
- Multi-omics analysis reveals the association between specific solute carrier proteins gene expression patterns and the immune suppressive microenvironment in glioma
- Neuroblastoma-like schwannoma of the lung: report of a case
- Orexin-A mediates glioblastoma proliferation inhibition by increasing ferroptosis triggered by unstable iron pools and GPX4 depletion
- PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma
- Peak Resembling N-acetylaspartate (NAA) on Magnetic Resonance Spectroscopy of Brain Metastases
- Pilocytic astrocytoma with KRAS gene mutation: a clinicopathological analysis of two cases
- Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma
- Prediction of High-Risk Neuroblastoma Among Neuroblastic Tumors Using Radiomics Features Derived from Magnetic Resonance Imaging: A Pilot Study
- Predictive Model to Identify the Long Time Survivor in Patients with Glioblastoma: A Cohort Study Integrating Machine Learning Algorithms
- Principles in the Management of Glioblastoma
- Proteasome inhibitors induce apoptosis by superoxide anion generation via NADPH oxidase 5 in human neuroblastoma SH-SY5Y cells
- Radiological and Not Clinical Variables Guide the Surgical Plan in Patients with Glioblastoma
- RAPID resistance to BET inhibitors is mediated by FGFR1 in glioblastoma
- Resiquimod Induces C-C Motif Chemokine Ligand 2 Via Nuclear Factor-Kappa B in SH-SY5Y Human Neuroblastoma Cells
- Review of Patient Gene Profiles Obtained through a Non-Negative Matrix Factorization-Based Framework to Determine the Role Inflammation Plays in Neuroblastoma Pathogenesis
- Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas
- Riluzole Reverses a Number of Undesirable Effects of Dexamethasone in Glioblastoma Cells
- Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma
- Roles of TRPM channels in glioma
- ScRNA-seq reveals novel immune-suppressive T cells and investigates CMV-TCR-T cells cytotoxicity against GBM
- Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysis
- SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis
- St. John's wort extract Ze 117 alters the membrane fluidity of C6 glioma cells by influencing cellular cholesterol metabolism
- Structural- and DTI- MRI enable automated prediction of IDH Mutation Status in CNS WHO Grade 2-4 glioma patients: a deep Radiomics Approach
- SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201)
- Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification
- Survival Outcome Prediction in Glioblastoma: Insights from MRI Radiomics
- Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier
- Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma
- The <em>OTX2</em> Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas
- The Expression of Serglycin Is Required for Active Transforming Growth Factor β Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2
- The Father of Wisdom: "The Influence of Surgical Experience on Overall Survival in Patients with Malignant Gliomas"
- The ins and outs of microglial cells in brain health and disease
- The multifaceted functions of long non-coding RNA <em>HOTAIR</em> in neuropathologies and its potential as a prognostic marker and therapeutic biotarget
- The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human Glioma
- Therapeutic efficacy of a novel self-assembled immunostimulatory siRNA combining apoptosis promotion with RIG-I activation in gliomas
- Two hits are better than one: rational dual strategy efficiently fights neuroblastoma
- Two-headed UNetEfficientNets for parallel execution of segmentation and classification of brain tumors: incorporating postprocessing techniques with connected component labelling
- VC-resist glioblastoma cell state: vessel co-option as a key driver of chemoradiation resistance
- VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis
- Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy